# PathogenDx, Inc. — Form D

PathogenDx, Inc. of SCOTTSDALE, AZ, a company, filed a Form D exempt-offering notice with the SEC on 2016-04-19. The offering totals $1.2M, of which $675K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2016-04-19
- Form: D
- Accession: 0001669428-16-000001
- Industry: Biotechnology
- Exemptions: 05
- Total offering: $1.2M
- Amount sold: $675K
- Remaining: $525K
- Minimum investment: $50K
- Investors: 4
- Date of first sale: 2016-04-11
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-261653

## Issuer

- Name: PathogenDx, Inc.
- CIK: 0001669428
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 9375 E. SHEA BLVD, SCOTTSDALE, AZ, 85260
- Phone: 2026644711

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| Michael Hogan | Director | Indianapolis, IN |
| Eric Lachance | Director | Scottsdale, AZ |
| Milan Patel | Director | CHICAGO, IL |
| Michael Hogan | Executive Officer | Indianapolis, IN |
| Eric Lachance | Executive Officer | Scottsdale, AZ |
| Milan Patel | Executive Officer | CHICAGO, IL |

## More

- [CIK 1669428 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1669428&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001669428-16-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.